Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma
10.1007/s13139-024-00847-4
- Author:
Dongwoo KIM
1
;
Suk‑Hyun LEE
;
Hee Sung HWANG
;
Sun Jung KIM
;
Mijin YUN
Author Information
1. Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, 50‑1 Yonsei‑Ro, Seodaemun‑Gu, Seoul 03722, Republic of Korea
- Publication Type:REVIEW
- From:Nuclear Medicine and Molecular Imaging
2024;58(4):237-245
- CountryRepublic of Korea
- Language:English
-
Abstract:
Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering complementary insights to those gained through magnetic resonance imaging (MRI). PET/CT scans enable a multifaceted analysis of glioma biology, supporting clinical applications from grading and differential diagnosis to mapping the full extent of tumors and planning subsequent treatments and evaluations. With a broad array of specialized radiotracers, researchers and clinicians can now probe various biological characteristics of gliomas, such as glucose utilization, cellular proliferation, oxygen deficiency, amino acid trafficking, and reactive astrogliosis. This review aims to provide a recent update on the application of versatile PET/CT radiotracers in glioma research and clinical practice.
